Annotations
Cell Type Ontology
native cell (CL:0000003)
A cell that is found in a natural setting, which includes multicellular organism cells 'in vivo' (i.e. part of an organism), and unicellular organisms 'in environment' (i.e. part of a natural environment).|To accommodate unicellular organisms better, 'cell in vivo' has been re-labeled 'native cell' to better represent its intended meaning - that is, that it is a cell in the context of a multicellular organism or in a natural environment. 'Native' is intended to contrast with 'in vitro', which refers to cells or other biological entities that have been intentionally placed in a controlled, non-natural setting for the purpose of study or manipulation. (MAH 1.12.12).
Table Filters- ACE inhibitor pathway - WP554 (Homo sapiens)
- Acetaminophen in analgesia and antipyresis - WP5444 (Homo sapiens)
- Acetate mediated promotion of metabolic syndrome - WP3650 (Rattus norvegicus)
- Acetylcholine synthesis - WP528 (Homo sapiens)
- Acquired partial lipodystrophy / Barraquer-Simons syndrome - WP5104 (Homo sapiens)
- Acrylamide biotransformation and exposure biomarkers - WP4233 (Homo sapiens)
- Acute viral myocarditis - WP4298 (Homo sapiens)
- Airway smooth muscle cell contraction - WP4962 (Homo sapiens)
- Altered glycosylation of MUC1 in tumor microenvironment - WP4480 (Homo sapiens)
- Angiopoietin-like protein 8 regulatory pathway - WP3915 (Homo sapiens)
- Angiotensin II receptor type 1 pathway - WP5036 (Homo sapiens)
- Arsenic liver toxicity pathway - WP5228 (Homo sapiens)
- B cell receptor signaling pathway - WP1025 (Bos taurus)
- B cell receptor signaling pathway - WP23 (Homo sapiens)
- Benzene metabolism - WP3891 (Homo sapiens)
- Bile acid synthesis and enterohepatic circulation - WP4389 (Homo sapiens)
- Burn wound healing - WP5055 (Homo sapiens)
- Burn wound healing - WP5056 (Mus musculus)
- Burn wound healing - WP5057 (Rattus norvegicus)
- Burn wound healing - WP5058 (Sus scrofa)
- COVID-19, thrombosis and anticoagulation - WP4927 (Homo sapiens)
- Calcium regulation in cardiac cell - WP1043 (Bos taurus)
- Calcium regulation in cardiac cells - WP1159 (Canis familiaris)
- Calcium regulation in cardiac cells - WP536 (Homo sapiens)
- Calcium regulation in cardiac cells - WP553 (Mus musculus)
- Calcium regulation in cardiac cells - WP808 (Gallus gallus)
- Calcium regulation in cardiac cells - WP923 (Pan troglodytes)
- Cancer immunotherapy by CTLA4 blockade - WP4582 (Homo sapiens)
- Cancer immunotherapy by PD-1 blockade - WP4585 (Homo sapiens)
- Cannabinoid receptor signaling - WP3869 (Homo sapiens)
- Canonical and non-canonical TGF-B signaling - WP3874 (Homo sapiens)
- Cardiac hypertrophic response - WP2795 (Homo sapiens)
- Cardiac progenitor differentiation - WP2406 (Homo sapiens)
- Cardiac progenitor differentiation - WP3127 (Bos taurus)
- Cardiomyocyte signaling pathways converging on titin - WP5344 (Homo sapiens)
- Cell interactions of the pancreatic cancer microenvironment - WP5284 (Homo sapiens)
- Cell lineage map for neuronal differentiation - WP5417 (Homo sapiens)
- Cholestasis - WP5238 (Homo sapiens)
- Cholesterol biosynthesis pathway in hepatocytes - WP5329 (Homo sapiens)
- Cholesterol metabolism - WP5304 (Homo sapiens)
- Circulating monocytes and cardiac macrophages in diastolic dysfunction - WP4474 (Mus musculus)
- Clock-controlled autophagy in bone metabolism - WP5205 (Homo sapiens)
- Codeine and morphine metabolism - WP1604 (Homo sapiens)
- Complement system in neuronal development and plasticity - WP5090 (Homo sapiens)
- Copper metabolism - WP5189 (Homo sapiens)
- Cytokines and inflammatory response - WP530 (Homo sapiens)
- Deregulation of renin-angiotensin system by SARS-CoV infection - WP4965 (Mus musculus)
- Development and heterogeneity of the ILC family - WP3893 (Homo sapiens)
- Development of pulmonary dendritic cells and macrophage subsets - WP3892 (Homo sapiens)
- Disorders in ketone body synthesis - WP5175 (Homo sapiens)
- Disorders of bile acid synthesis and biliary transport - WP5176 (Homo sapiens)
- Dopamine metabolism - WP2436 (Homo sapiens)
- Drug induction of bile acid pathway - WP2289 (Homo sapiens)
- Drug induction of bile acid pathway - WP3253 (Bos taurus)
- EDA signaling in hair follicle development - WP3930 (Homo sapiens)
- EV release from cardiac cells and their functional effects - WP3297 (Homo sapiens)
- Ectodysplasin A signaling in hair follicle development - WP3652 (Mus musculus)
- Effect of L-carnitine on metabolism - WP3992 (Danio rerio)
- Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists - WP5273 (Homo sapiens)
- Endothelin pathways - WP2197 (Homo sapiens)
- Endothelin pathways - WP3246 (Bos taurus)
- Enterocyte cholesterol metabolism - WP5333 (Homo sapiens)
- Enterohepatic circulation of bile acids - WP5396 (Homo sapiens)
- Estradiol regulation in porto-sinusoidal vascular disease - WP5235 (Homo sapiens)
- Evolocumab mechanism to reduce LDL cholesterol - WP3408 (Homo sapiens)
- Exercise-induced circadian regulation - WP410 (Homo sapiens)
- Exercise-induced circadian regulation - WP544 (Mus musculus)
- Extracellular vesicles in the crosstalk of cardiac cells - WP4300 (Homo sapiens)
- Extrafollicular and follicular B cell activation by SARS-CoV-2 - WP5218 (Homo sapiens)
- FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma - WP4553 (Homo sapiens)
- FGF23 signaling in hypophosphatemic rickets and related disorders - WP4790 (Homo sapiens)
- FGFR4 p.G388R signaling pathway - WP5428 (Homo sapiens)
- FOXP3 in COVID-19 - WP5063 (Homo sapiens)
- FSH signaling pathway - WP3158 (Bos taurus)
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling - WP3675 (Mus musculus)
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling - WP3850 (Homo sapiens)
- Fatty acids and lipoproteins transport in hepatocytes - WP5323 (Homo sapiens)
- Fibrin complement receptor 3 signaling pathway - WP4136 (Homo sapiens)
- Fibrin complement receptor 3 signaling pathway - WP5128 (Mus musculus)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Fluoropyrimidine activity - WP3275 (Bos taurus)
- Follicle stimulating hormone (FSH) signaling pathway - WP2035 (Homo sapiens)
- Frustrated phagocytosis leading to malignant pleural mesothelioma - WP5091 (Homo sapiens)
- GLP-1 from intestine and pancreas and role in glucose homeostasis - WP5452 (Homo sapiens)
- GLP-1 in pancreatic islet cells - WP5447 (Homo sapiens)
- GLP-1 secretion from intestine to portal vein - WP5446 (Homo sapiens)
- GNAQ pathways in port-wine stain - WP5437 (Homo sapiens)
- GPR143 in melanocytes and retinal pigment epithelium cells - WP4941 (Homo sapiens)
- Gastric acid production - WP2596 (Homo sapiens)
- Gastrin signaling pathway - WP4659 (Homo sapiens)
- Genes targeted by miRNAs in adipocytes - WP1992 (Homo sapiens)
- Glioblastoma signaling pathways - WP2261 (Homo sapiens)
- Glyoxylate metabolism - WP5166 (Homo sapiens)
- Gonadotropin-releasing hormone (GnRH) signaling - WP2901 (Bos taurus)
- Growth factors and hormones in beta cell proliferation - WP5385 (Homo sapiens)
- Hair follicle development: cytodifferentiation - part 3 of 3 - WP2840 (Homo sapiens)
- Hair follicle development: organogenesis - part 2 of 3 - WP2839 (Homo sapiens)
- Heart development - WP1591 (Homo sapiens)
- Heart development - WP2067 (Mus musculus)
- Heart development - WP3280 (Bos taurus)
- Hematopoietic stem cell differentiation - WP2849 (Homo sapiens)
- Hematopoietic stem cell differentiation - WP3174 (Bos taurus)
- Hemesynthesis defects and porphyrias - WP5169 (Homo sapiens)
- Hepatitis B infection - WP4666 (Homo sapiens)
- Hepatocyte growth factor receptor signaling - WP1046 (Bos taurus)
- Hepatocyte growth factor receptor signaling - WP313 (Homo sapiens)
- Hepatocyte growth factor receptor signaling - WP927 (Pan troglodytes)
- Hepatocyte growth factor receptor signaling - WP94 (Rattus norvegicus)
- Hijack of ubiquitination by SARS-CoV-2 - WP4860 (Homo sapiens)
- Hunger and satiety - WP5445 (Homo sapiens)
- Hypertrophy model - WP516 (Homo sapiens)
- Hypoxia-dependent differentiation of myoblasts - WP5025 (Mus musculus)
- Hypoxia-dependent proliferation of myoblasts - WP5024 (Mus musculus)
- Hypoxia-dependent self-renewal of myoblasts - WP5023 (Mus musculus)
- IL-10 anti-inflammatory signaling pathway - WP4495 (Homo sapiens)
- Imatinib and chronic myeloid leukemia - WP3640 (Homo sapiens)
- Immune infiltration in pancreatic cancer - WP5285 (Homo sapiens)
- Inclusion body myositis - WP5120 (Homo sapiens)
- Inflammatory bowel disease signaling - WP5198 (Homo sapiens)
- Inflammatory response pathway - WP453 (Homo sapiens)
- Influence of laminopathies on Wnt signaling - WP4844 (Homo sapiens)
- Insulin induced PI3K-Akt and MAPK in hepatocytes - WP4229 (Rattus norvegicus)
- Insulin signaling in adipocytes (diabetic condition) - WP3635 (Homo sapiens)
- Insulin signaling in adipocytes (normal condition) - WP3634 (Homo sapiens)
- Interactions between immune cells and microRNAs in tumor microenvironment - WP4559 (Homo sapiens)
- Interactions of natural killer cells in pancreatic cancer - WP5092 (Homo sapiens)
- Irinotecan pathway - WP1080 (Bos taurus)
- Irinotecan pathway - WP229 (Homo sapiens)
- Iron metabolism disorders - WP5172 (Homo sapiens)
- JAK-STAT signaling in the regulation of beta cells - WP5358 (Homo sapiens)
- Ketogenesis and ketolysis - WP4742 (Homo sapiens)
- LDL- influence on CD14 and TLR4 - WP5272 (Homo sapiens)
- Leukocyte-intrinsic Hippo pathway functions - WP4542 (Homo sapiens)
- Lipid metabolism pathway - WP3965 (Homo sapiens)
- Liver steatosis adverse outcome pathway - WP4010 (Homo sapiens)
- MET in type 1 papillary renal cell carcinoma - WP4205 (Homo sapiens)
- MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement - WP4560 (Homo sapiens)
- Macrophage markers - WP2271 (Mus musculus)
- Macrophage markers - WP4146 (Homo sapiens)
- Male infertility - WP4673 (Homo sapiens)
- Mammary gland development pathway - Embryonic development (Stage 1 of 4) - WP2813 (Homo sapiens)
- Mammary gland development pathway - Involution (Stage 4 of 4) - WP2815 (Homo sapiens)
- Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) - WP2817 (Homo sapiens)
- Mammary gland development pathway - Puberty (Stage 2 of 4) - WP2814 (Homo sapiens)
- Markers of kidney cell lineage - WP5236 (Homo sapiens)
- Measles virus infection - WP4630 (Homo sapiens)
- MicroRNA network associated with chronic lymphocytic leukemia - WP4399 (Homo sapiens)
- Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors - WP4397 (Homo sapiens)
- Modulators of TCR signaling and T cell activation - WP5072 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP140 (Rattus norvegicus)
- Myometrial relaxation and contraction pathways - WP289 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP3276 (Bos taurus)
- Myometrial relaxation and contraction pathways - WP385 (Mus musculus)
- Nanomaterial-induced inflammasome activation - WP3890 (Homo sapiens)
- Neovascularization processes - WP4331 (Homo sapiens)
- Neural crest cell migration during development - WP4564 (Homo sapiens)
- Neural crest cell migration in cancer - WP4565 (Homo sapiens)
- Neural crest differentiation - WP2064 (Homo sapiens)
- Neural crest differentiation - WP2074 (Mus musculus)
- Neural crest differentiation - WP3273 (Bos taurus)
- Nicotine activity on chromaffin cells - WP3255 (Bos taurus)
- Nicotine activity on dopaminergic neurons - WP3179 (Bos taurus)
- Nicotine effect on chromaffin cells - WP1603 (Homo sapiens)
- Nicotine effect on dopaminergic neurons - WP1602 (Homo sapiens)
- Nicotine metabolism - WP3185 (Bos taurus)
- Nicotine metabolism in liver cells - WP1600 (Homo sapiens)
- Nonalcoholic fatty liver disease - WP4396 (Homo sapiens)
- OSX and miRNAs in tooth development - WP3971 (Homo sapiens)
- Oligodendrocyte specification and differentiation, leading to myelin components for CNS - WP4304 (Homo sapiens)
- Ophthalmate biosynthesis in hepatocytes - WP4487 (Homo sapiens)
- Osteoblast differentiation and related diseases - WP4787 (Homo sapiens)
- Osteoblast signaling - WP1074 (Bos taurus)
- Osteoblast signaling - WP227 (Rattus norvegicus)
- Osteoblast signaling - WP238 (Mus musculus)
- Osteoblast signaling - WP322 (Homo sapiens)
- Osteoblast signaling - WP956 (Pan troglodytes)
- Ovarian infertility - WP273 (Mus musculus)
- Ovarian infertility - WP34 (Homo sapiens)
- Oxidation by cytochrome P450 - WP1077 (Bos taurus)
- Oxidation by cytochrome P450 - WP43 (Homo sapiens)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- Oxytocin signaling - WP2889 (Homo sapiens)
- PCSK9-mediated LDL receptor degradation - WP2846 (Homo sapiens)
- PPAR signaling pathway - WP2316 (Mus musculus)
- PPAR signaling pathway - WP3942 (Homo sapiens)
- Parkinson's disease pathway - WP2371 (Homo sapiens)
- Physiological and pathological hypertrophy of the heart - WP1528 (Homo sapiens)
- Platelet-mediated interactions with vascular and circulating cells - WP4462 (Homo sapiens)
- Pleural mesothelioma - WP5087 (Homo sapiens)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2572 (Homo sapiens)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2573 (Mus musculus)
- Primary focal segmental glomerulosclerosis (FSGS) - WP3233 (Bos taurus)
- Prostaglandin signaling - WP5088 (Homo sapiens)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- ROS in COVID-19 endothelial dysfunction - WP5258 (Homo sapiens)
- Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle - WP4763 (Mus musculus)
- Retinol metabolism - WP5188 (Homo sapiens)
- Role of carnosine in muscle contraction - WP4486 (Homo sapiens)
- Roles of ceramides in development of insulin resistance - WP5181 (Homo sapiens)
- SIDS susceptibility pathways - WP3130 (Bos taurus)
- SREBP signaling - WP3194 (Bos taurus)
- SRF and miRs in smooth muscle differentiation and proliferation - WP1991 (Homo sapiens)
- Selective expression of chemokine receptors during T-cell polarization - WP4494 (Homo sapiens)
- Serotonin and anxiety - WP2141 (Mus musculus)
- Serotonin and anxiety - WP3947 (Homo sapiens)
- Statin inhibition of cholesterol production - WP430 (Homo sapiens)
- Statin pathway - WP1 (Mus musculus)
- Statin pathway - WP1041 (Bos taurus)
- Statin pathway - WP145 (Rattus norvegicus)
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982 (Homo sapiens)
- Striated muscle contraction - WP969 (Bos taurus)
- Striated muscle contraction pathway - WP383 (Homo sapiens)
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706 (Homo sapiens)
- T cell modulation in pancreatic cancer - WP5078 (Homo sapiens)
- T cell receptor and co-stimulatory signaling - WP2583 (Homo sapiens)
- T-cell activation SARS-CoV-2 - WP5098 (Homo sapiens)
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863 (Homo sapiens)
- T-cell receptor signaling pathway - WP69 (Homo sapiens)
- Th17 cell differentiation pathway - WP5130 (Homo sapiens)
- Thermogenesis - WP4321 (Homo sapiens)
- Transcription factor regulation in adipogenesis - WP3599 (Homo sapiens)
- Transcription factors regulate miRNAs related to cardiac hypertrophy - WP1559 (Homo sapiens)
- Transcriptional cascade regulating adipogenesis - WP4211 (Homo sapiens)
- Tryptophan metabolism - WP465 (Homo sapiens)
- Type II diabetes mellitus - WP1584 (Homo sapiens)
- Type II diabetes mellitus - WP3117 (Bos taurus)
- Type II interferon signaling (IFNG) - WP1253 (Mus musculus)
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
- Urea cycle and related diseases - WP4571 (Homo sapiens)
- VEGFA-VEGFR2 signaling - WP3888 (Homo sapiens)
- Valproic acid pathway - WP3871 (Homo sapiens)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- Vitamin D metabolism - WP1531 (Homo sapiens)
- Vitamin D metabolism - WP3162 (Bos taurus)
- Vitamin K metabolism and activation of dependent proteins - WP5186 (Homo sapiens)
- White fat cell differentiation - WP2872 (Mus musculus)
- White fat cell differentiation - WP4149 (Homo sapiens)
- mRNA vaccine activation of dendritic cell and induction of IFN-1 - WP5187 (Homo sapiens)
- miR-222 in exercise-induced cardiac growth - WP2928 (Mus musculus)
- miR-222 in exercise-induced cardiac growth - WP3938 (Homo sapiens)
- miR302-367 promoting cardiomyocyte proliferation - WP2904 (Mus musculus)
- ncRNAs involved in STAT3 signaling in hepatocellular carcinoma - WP4337 (Homo sapiens)
- ncRNAs involved in Wnt signaling in hepatocellular carcinoma - WP4336 (Homo sapiens)